[1]
N. rao, R. Jauhari, P. Godiyal, V. Sati, and A. Babbar, “ROPINIROLE VERSUS LEVODOPA: BETTER CLINICAL BENEFITS IN PARKINSON’S DISEASE”, journal, vol. 5, no. 3, pp. 17-27, Dec. 2022.